EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Oncostatin M: friend or foe in PCOS pathogenesis?

Saba Nikanfar, Farnaz Oghbaei, Hamid R Nejabati, Reza Zarezadeh, Zeinab Latifi, Sanya Hayati Laleh, Lida Khodavirdilou, Rasa Khodavirdilou, Christiani A Amorim, Amir Fattahi iD

Journal of Endocrinology · 2024

DOI: 10.1530/joe-24-0140 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Endocrinology, 2024. Verfasst von Saba Nikanfar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Oncostatin M, Insulin Resistance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a primary endocrinological disorder in women of reproductive age that is characterized by androgen excess and ovulatory irregularities. This syndrome is associated with adipose tissue dysfunction, an elevated risk of insulin resistance, hyperinsulinemia, obesity, and type 2 diabetes. Adipocyte dysfunction affects the secretion of adipokines and pro-inflammatory cytokines. Nevertheless, adipose tissue is not an exclusive source of adipokines as it can also be produced locally by reproductive tissues. Although adipokines have been recognized in the development of PCOS, the role of oncostatin M (OSM), a multifaceted adipokine, remains unclear. Current evidence suggests that this cytokine is associated with key aspects of the syndrome, including obesity, insulin resistance, hyperandrogenism, and inflammation. However, the data are often contradictory, likely due to variations in study designs, methodologies, and species differences. By investigating the link between OSM and PCOS-associated issues, this review identified the potential role of this adipokine in PCOS pathogenesis. This underscores the need for further research to clarify its predominant effects and assess its relevance as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeOncostatin MInsulin ResistanceHumansFemaleObesityAnimalsAdipokinesHyperandrogenismAdipose TissueInflammation

Stichwörter der Autor:innen

PCOSinsulin resistanceobesityoncostatin Movarian function

Substanzen

Oncostatin MAdipokines

Autor:innen und Institutionen

  • Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
  • Healthy Ageing Research Center, Neyshabur University of Medical Sceieces, Neyshabur, Iran.
  • Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
  • Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center (TTUHSC), Amarillo, TX, USA.

ORCID-Profile: Amir Fattahi

Zitieren

APA

Nikanfar, S., Oghbaei, F., Nejabati, H. R., Zarezadeh, R., Latifi, Z., Laleh, S. H., Khodavirdilou, L., Khodavirdilou, R., Amorim, C. A., & Fattahi, A. (2024). Oncostatin M: friend or foe in PCOS pathogenesis?. Journal of Endocrinology. https://doi.org/10.1530/joe-24-0140

Vancouver

Nikanfar S, Oghbaei F, Nejabati HR, Zarezadeh R, Latifi Z, Laleh SH, et al. Oncostatin M: friend or foe in PCOS pathogenesis?. Journal of Endocrinology. 2024. doi:10.1530/joe-24-0140

BibTeX
@article{Nikanfar2024,
  author = {Nikanfar, Saba and Oghbaei, Farnaz and Nejabati, Hamid R and Zarezadeh, Reza and Latifi, Zeinab and Laleh, Sanya Hayati and Khodavirdilou, Lida and Khodavirdilou, Rasa and Amorim, Christiani A and Fattahi, Amir},
  title = {Oncostatin M: friend or foe in PCOS pathogenesis?},
  journal = {Journal of Endocrinology},
  year = {2024},
  doi = {10.1530/joe-24-0140}
}
Kostenlos starten →